GLPG Galapagos NV ADRs

Galapagos NV is a clinical-stage biotechnology company. It is engaged in the discovery and development of small molecule medicines which address unmet medical conditions. This is an ADR of a company whose stock trades outside of the U.S. as the symbol NA:GLPG.

$82.57  -2.57 (-3.02%)
As of 02/26/2021 15:59:50 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
ADRs
Mid cap
Health Care
Biotechnology
Belgium
Belgium
07/07/2008
65,411,767
425,882
$5,569,157,842
0.00%
SEC Edgar Online
20-F
36315X101
US36315X1019
B292NQ7

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
60.65
3.34
10.86
-13.39%
-70.80%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy